nodes	percent_of_prediction	percent_of_DWPC	metapath
Abiraterone—ABCC1—Dactinomycin—kidney cancer	0.0788	0.118	CbGbCtD
Abiraterone—ORM1—Erlotinib—kidney cancer	0.0674	0.101	CbGbCtD
Abiraterone—ABCC1—Paclitaxel—kidney cancer	0.0563	0.084	CbGbCtD
Abiraterone—ABCC1—Vinblastine—kidney cancer	0.0493	0.0737	CbGbCtD
Abiraterone—ABCC1—Vincristine—kidney cancer	0.0485	0.0724	CbGbCtD
Abiraterone—CYP2D6—Temsirolimus—kidney cancer	0.0373	0.0557	CbGbCtD
Abiraterone—CYP3A4—Everolimus—kidney cancer	0.0351	0.0524	CbGbCtD
Abiraterone—CYP2C8—Pazopanib—kidney cancer	0.0307	0.0458	CbGbCtD
Abiraterone—ABCC1—Doxorubicin—kidney cancer	0.0303	0.0453	CbGbCtD
Abiraterone—ALB—Erlotinib—kidney cancer	0.0283	0.0423	CbGbCtD
Abiraterone—CYP3A4—Temsirolimus—kidney cancer	0.0237	0.0354	CbGbCtD
Abiraterone—CYP2C8—Erlotinib—kidney cancer	0.0219	0.0327	CbGbCtD
Abiraterone—CYP2C8—Paclitaxel—kidney cancer	0.0201	0.0299	CbGbCtD
Abiraterone—CYP2D6—Pazopanib—kidney cancer	0.0196	0.0292	CbGbCtD
Abiraterone—CYP2C8—Sorafenib—kidney cancer	0.0178	0.0266	CbGbCtD
Abiraterone—CYP2D6—Erlotinib—kidney cancer	0.014	0.0209	CbGbCtD
Abiraterone—CYP3A4—Pazopanib—kidney cancer	0.0125	0.0186	CbGbCtD
Abiraterone—CYP2D6—Sorafenib—kidney cancer	0.0114	0.017	CbGbCtD
Abiraterone—CYP2D6—Vinblastine—kidney cancer	0.0112	0.0168	CbGbCtD
Abiraterone—CYP3A4—Erlotinib—kidney cancer	0.00888	0.0133	CbGbCtD
Abiraterone—CYP3A4—Paclitaxel—kidney cancer	0.00813	0.0121	CbGbCtD
Abiraterone—CYP3A4—Sorafenib—kidney cancer	0.00722	0.0108	CbGbCtD
Abiraterone—CYP3A4—Vinblastine—kidney cancer	0.00713	0.0107	CbGbCtD
Abiraterone—CYP3A4—Vincristine—kidney cancer	0.00701	0.0105	CbGbCtD
Abiraterone—CYP2D6—Doxorubicin—kidney cancer	0.00689	0.0103	CbGbCtD
Abiraterone—CYP3A4—Sunitinib—kidney cancer	0.00585	0.00874	CbGbCtD
Abiraterone—CYP3A4—Doxorubicin—kidney cancer	0.00438	0.00654	CbGbCtD
Abiraterone—SULT2A1—gonad—kidney cancer	0.00242	0.168	CbGeAlD
Abiraterone—CYP3A4—urine—kidney cancer	0.00141	0.0976	CbGeAlD
Abiraterone—CYP2D6—urine—kidney cancer	0.00139	0.0961	CbGeAlD
Abiraterone—CYP17A1—nephron tubule—kidney cancer	0.00129	0.0896	CbGeAlD
Abiraterone—CYP17A1—renal system—kidney cancer	0.00117	0.0815	CbGeAlD
Abiraterone—CYP17A1—kidney—kidney cancer	0.00114	0.0788	CbGeAlD
Abiraterone—CYP17A1—cortex of kidney—kidney cancer	0.00111	0.0767	CbGeAlD
Abiraterone—CYP17A1—gonad—kidney cancer	0.00105	0.0731	CbGeAlD
Abiraterone—ABCC1—cortex of kidney—kidney cancer	0.000562	0.039	CbGeAlD
Abiraterone—ABCC1—cardiac atrium—kidney cancer	0.000535	0.0371	CbGeAlD
Abiraterone—CYP2C8—renal system—kidney cancer	0.000508	0.0353	CbGeAlD
Abiraterone—CYP2C8—kidney—kidney cancer	0.000492	0.0341	CbGeAlD
Abiraterone—CYP3A4—renal system—kidney cancer	0.000344	0.0239	CbGeAlD
Abiraterone—CYP2D6—renal system—kidney cancer	0.000339	0.0235	CbGeAlD
Abiraterone—CYP3A4—kidney—kidney cancer	0.000333	0.0231	CbGeAlD
Abiraterone—CYP2D6—kidney—kidney cancer	0.000328	0.0227	CbGeAlD
Abiraterone—Infestation NOS—Paclitaxel—kidney cancer	0.00026	0.00105	CcSEcCtD
Abiraterone—Infestation—Paclitaxel—kidney cancer	0.00026	0.00105	CcSEcCtD
Abiraterone—Musculoskeletal discomfort—Erlotinib—kidney cancer	0.000259	0.00105	CcSEcCtD
Abiraterone—Cardiac disorder—Gemcitabine—kidney cancer	0.000258	0.00105	CcSEcCtD
Abiraterone—Insomnia—Erlotinib—kidney cancer	0.000257	0.00104	CcSEcCtD
Abiraterone—Chest pain—Sunitinib—kidney cancer	0.000257	0.00104	CcSEcCtD
Abiraterone—Myalgia—Sunitinib—kidney cancer	0.000257	0.00104	CcSEcCtD
Abiraterone—Mental disorder—Vincristine—kidney cancer	0.000257	0.00104	CcSEcCtD
Abiraterone—Acute coronary syndrome—Paclitaxel—kidney cancer	0.000256	0.00104	CcSEcCtD
Abiraterone—Diarrhoea—Pazopanib—kidney cancer	0.000256	0.00104	CcSEcCtD
Abiraterone—Unspecified disorder of skin and subcutaneous tissue—Sunitinib—kidney cancer	0.000255	0.00104	CcSEcCtD
Abiraterone—Gastrointestinal disorder—Everolimus—kidney cancer	0.000255	0.00103	CcSEcCtD
Abiraterone—Myocardial infarction—Paclitaxel—kidney cancer	0.000254	0.00103	CcSEcCtD
Abiraterone—Infection—Sorafenib—kidney cancer	0.000254	0.00103	CcSEcCtD
Abiraterone—Fatigue—Everolimus—kidney cancer	0.000254	0.00103	CcSEcCtD
Abiraterone—Dyspnoea—Erlotinib—kidney cancer	0.000254	0.00103	CcSEcCtD
Abiraterone—Constipation—Vinblastine—kidney cancer	0.000253	0.00103	CcSEcCtD
Abiraterone—Angiopathy—Gemcitabine—kidney cancer	0.000253	0.00102	CcSEcCtD
Abiraterone—Urinary tract infection—Paclitaxel—kidney cancer	0.000252	0.00102	CcSEcCtD
Abiraterone—Constipation—Everolimus—kidney cancer	0.000252	0.00102	CcSEcCtD
Abiraterone—Vomiting—Temsirolimus—kidney cancer	0.000252	0.00102	CcSEcCtD
Abiraterone—Hypokalaemia—Capecitabine—kidney cancer	0.000252	0.00102	CcSEcCtD
Abiraterone—Mediastinal disorder—Gemcitabine—kidney cancer	0.000251	0.00102	CcSEcCtD
Abiraterone—Dyspepsia—Erlotinib—kidney cancer	0.000251	0.00102	CcSEcCtD
Abiraterone—Rash—Temsirolimus—kidney cancer	0.00025	0.00101	CcSEcCtD
Abiraterone—Dermatitis—Temsirolimus—kidney cancer	0.00025	0.00101	CcSEcCtD
Abiraterone—Aspartate aminotransferase increased—Capecitabine—kidney cancer	0.000249	0.00101	CcSEcCtD
Abiraterone—Skin disorder—Sorafenib—kidney cancer	0.000249	0.00101	CcSEcCtD
Abiraterone—Arrhythmia—Gemcitabine—kidney cancer	0.000249	0.00101	CcSEcCtD
Abiraterone—Haematuria—Paclitaxel—kidney cancer	0.000248	0.001	CcSEcCtD
Abiraterone—Nasopharyngitis—Capecitabine—kidney cancer	0.000247	0.001	CcSEcCtD
Abiraterone—Oedema—Sunitinib—kidney cancer	0.000246	0.001	CcSEcCtD
Abiraterone—Gastrointestinal disorder—Erlotinib—kidney cancer	0.000246	0.000997	CcSEcCtD
Abiraterone—Phosphatase alkaline increased—Doxorubicin—kidney cancer	0.000245	0.000996	CcSEcCtD
Abiraterone—Fatigue—Erlotinib—kidney cancer	0.000245	0.000995	CcSEcCtD
Abiraterone—Infection—Sunitinib—kidney cancer	0.000245	0.000993	CcSEcCtD
Abiraterone—Alanine aminotransferase increased—Capecitabine—kidney cancer	0.000244	0.000989	CcSEcCtD
Abiraterone—Constipation—Erlotinib—kidney cancer	0.000243	0.000987	CcSEcCtD
Abiraterone—Myalgia—Dactinomycin—kidney cancer	0.000243	0.000987	CcSEcCtD
Abiraterone—Discomfort—Dactinomycin—kidney cancer	0.00024	0.000975	CcSEcCtD
Abiraterone—Skin disorder—Sunitinib—kidney cancer	0.000239	0.000971	CcSEcCtD
Abiraterone—Vomiting—Pazopanib—kidney cancer	0.000238	0.000964	CcSEcCtD
Abiraterone—Anaemia—Vincristine—kidney cancer	0.000236	0.000957	CcSEcCtD
Abiraterone—Rash—Pazopanib—kidney cancer	0.000236	0.000956	CcSEcCtD
Abiraterone—Dermatitis—Pazopanib—kidney cancer	0.000235	0.000955	CcSEcCtD
Abiraterone—Musculoskeletal discomfort—Sorafenib—kidney cancer	0.000233	0.000946	CcSEcCtD
Abiraterone—Oedema—Dactinomycin—kidney cancer	0.000233	0.000946	CcSEcCtD
Abiraterone—Body temperature increased—Everolimus—kidney cancer	0.000233	0.000946	CcSEcCtD
Abiraterone—Fluid retention—Doxorubicin—kidney cancer	0.000233	0.000945	CcSEcCtD
Abiraterone—Infection—Dactinomycin—kidney cancer	0.000232	0.00094	CcSEcCtD
Abiraterone—Urinary tract disorder—Paclitaxel—kidney cancer	0.00023	0.000933	CcSEcCtD
Abiraterone—Connective tissue disorder—Paclitaxel—kidney cancer	0.000229	0.000929	CcSEcCtD
Abiraterone—Urethral disorder—Paclitaxel—kidney cancer	0.000228	0.000927	CcSEcCtD
Abiraterone—Dyspnoea—Sorafenib—kidney cancer	0.000228	0.000926	CcSEcCtD
Abiraterone—Dyspepsia—Sorafenib—kidney cancer	0.000225	0.000914	CcSEcCtD
Abiraterone—Body temperature increased—Erlotinib—kidney cancer	0.000225	0.000913	CcSEcCtD
Abiraterone—Musculoskeletal discomfort—Sunitinib—kidney cancer	0.000225	0.000911	CcSEcCtD
Abiraterone—Anaemia—Gemcitabine—kidney cancer	0.000224	0.000908	CcSEcCtD
Abiraterone—Insomnia—Sunitinib—kidney cancer	0.000223	0.000904	CcSEcCtD
Abiraterone—Upper respiratory tract infection—Capecitabine—kidney cancer	0.000222	0.000901	CcSEcCtD
Abiraterone—Gastrointestinal disorder—Sorafenib—kidney cancer	0.000221	0.000897	CcSEcCtD
Abiraterone—Fatigue—Sorafenib—kidney cancer	0.000221	0.000896	CcSEcCtD
Abiraterone—Hypertension—Vincristine—kidney cancer	0.000221	0.000894	CcSEcCtD
Abiraterone—Dyspnoea—Sunitinib—kidney cancer	0.00022	0.000891	CcSEcCtD
Abiraterone—Constipation—Sorafenib—kidney cancer	0.000219	0.000888	CcSEcCtD
Abiraterone—Myalgia—Vincristine—kidney cancer	0.000217	0.000882	CcSEcCtD
Abiraterone—Dyspepsia—Sunitinib—kidney cancer	0.000217	0.00088	CcSEcCtD
Abiraterone—Cardiac disorder—Paclitaxel—kidney cancer	0.000216	0.000877	CcSEcCtD
Abiraterone—Hyperglycaemia—Capecitabine—kidney cancer	0.000216	0.000874	CcSEcCtD
Abiraterone—Pneumonia—Capecitabine—kidney cancer	0.000214	0.000869	CcSEcCtD
Abiraterone—Infestation NOS—Capecitabine—kidney cancer	0.000213	0.000864	CcSEcCtD
Abiraterone—Infestation—Capecitabine—kidney cancer	0.000213	0.000864	CcSEcCtD
Abiraterone—Gastrointestinal disorder—Sunitinib—kidney cancer	0.000213	0.000863	CcSEcCtD
Abiraterone—Musculoskeletal discomfort—Dactinomycin—kidney cancer	0.000213	0.000862	CcSEcCtD
Abiraterone—Asthenia—Vinblastine—kidney cancer	0.000213	0.000862	CcSEcCtD
Abiraterone—Fatigue—Sunitinib—kidney cancer	0.000212	0.000862	CcSEcCtD
Abiraterone—Asthenia—Everolimus—kidney cancer	0.000212	0.000859	CcSEcCtD
Abiraterone—Cough—Gemcitabine—kidney cancer	0.000211	0.000858	CcSEcCtD
Abiraterone—Angiopathy—Paclitaxel—kidney cancer	0.000211	0.000858	CcSEcCtD
Abiraterone—Constipation—Sunitinib—kidney cancer	0.000211	0.000855	CcSEcCtD
Abiraterone—Mediastinal disorder—Paclitaxel—kidney cancer	0.00021	0.000852	CcSEcCtD
Abiraterone—Acute coronary syndrome—Capecitabine—kidney cancer	0.00021	0.000852	CcSEcCtD
Abiraterone—Hypertension—Gemcitabine—kidney cancer	0.000209	0.000848	CcSEcCtD
Abiraterone—Myocardial infarction—Capecitabine—kidney cancer	0.000209	0.000847	CcSEcCtD
Abiraterone—Oedema—Vincristine—kidney cancer	0.000208	0.000845	CcSEcCtD
Abiraterone—Arrhythmia—Paclitaxel—kidney cancer	0.000208	0.000844	CcSEcCtD
Abiraterone—Infection—Vincristine—kidney cancer	0.000207	0.00084	CcSEcCtD
Abiraterone—Urinary tract infection—Capecitabine—kidney cancer	0.000207	0.00084	CcSEcCtD
Abiraterone—Myalgia—Gemcitabine—kidney cancer	0.000206	0.000837	CcSEcCtD
Abiraterone—Chest pain—Gemcitabine—kidney cancer	0.000206	0.000837	CcSEcCtD
Abiraterone—Blood alkaline phosphatase increased—Doxorubicin—kidney cancer	0.000205	0.000831	CcSEcCtD
Abiraterone—Unspecified disorder of skin and subcutaneous tissue—Gemcitabine—kidney cancer	0.000205	0.000831	CcSEcCtD
Abiraterone—Asthenia—Erlotinib—kidney cancer	0.000204	0.000828	CcSEcCtD
Abiraterone—Mental disorder—Paclitaxel—kidney cancer	0.000204	0.000828	CcSEcCtD
Abiraterone—Discomfort—Gemcitabine—kidney cancer	0.000204	0.000827	CcSEcCtD
Abiraterone—Haematuria—Capecitabine—kidney cancer	0.000203	0.000824	CcSEcCtD
Abiraterone—Diarrhoea—Vinblastine—kidney cancer	0.000203	0.000822	CcSEcCtD
Abiraterone—Body temperature increased—Sorafenib—kidney cancer	0.000202	0.000821	CcSEcCtD
Abiraterone—Diarrhoea—Everolimus—kidney cancer	0.000202	0.000819	CcSEcCtD
Abiraterone—Fatigue—Dactinomycin—kidney cancer	0.000201	0.000816	CcSEcCtD
Abiraterone—Oedema—Gemcitabine—kidney cancer	0.000198	0.000802	CcSEcCtD
Abiraterone—Infection—Gemcitabine—kidney cancer	0.000196	0.000797	CcSEcCtD
Abiraterone—Body temperature increased—Sunitinib—kidney cancer	0.000195	0.00079	CcSEcCtD
Abiraterone—Diarrhoea—Erlotinib—kidney cancer	0.000195	0.00079	CcSEcCtD
Abiraterone—Skin disorder—Gemcitabine—kidney cancer	0.000192	0.000779	CcSEcCtD
Abiraterone—Hot flush—Doxorubicin—kidney cancer	0.00019	0.000773	CcSEcCtD
Abiraterone—Musculoskeletal discomfort—Vincristine—kidney cancer	0.00019	0.00077	CcSEcCtD
Abiraterone—Urinary tract disorder—Capecitabine—kidney cancer	0.000189	0.000766	CcSEcCtD
Abiraterone—Menopausal symptoms—Doxorubicin—kidney cancer	0.000189	0.000766	CcSEcCtD
Abiraterone—Insomnia—Vincristine—kidney cancer	0.000189	0.000765	CcSEcCtD
Abiraterone—Vomiting—Vinblastine—kidney cancer	0.000188	0.000764	CcSEcCtD
Abiraterone—Connective tissue disorder—Capecitabine—kidney cancer	0.000188	0.000762	CcSEcCtD
Abiraterone—Vomiting—Everolimus—kidney cancer	0.000188	0.000761	CcSEcCtD
Abiraterone—Anaemia—Paclitaxel—kidney cancer	0.000188	0.00076	CcSEcCtD
Abiraterone—Urethral disorder—Capecitabine—kidney cancer	0.000187	0.00076	CcSEcCtD
Abiraterone—Rash—Everolimus—kidney cancer	0.000186	0.000755	CcSEcCtD
Abiraterone—Dermatitis—Everolimus—kidney cancer	0.000186	0.000754	CcSEcCtD
Abiraterone—Body temperature increased—Dactinomycin—kidney cancer	0.000184	0.000748	CcSEcCtD
Abiraterone—Asthenia—Sorafenib—kidney cancer	0.000184	0.000745	CcSEcCtD
Abiraterone—Cardiac failure—Doxorubicin—kidney cancer	0.000183	0.000741	CcSEcCtD
Abiraterone—Vomiting—Erlotinib—kidney cancer	0.000181	0.000734	CcSEcCtD
Abiraterone—Musculoskeletal discomfort—Gemcitabine—kidney cancer	0.00018	0.000731	CcSEcCtD
Abiraterone—Gastrointestinal disorder—Vincristine—kidney cancer	0.00018	0.00073	CcSEcCtD
Abiraterone—Fatigue—Vincristine—kidney cancer	0.00018	0.000729	CcSEcCtD
Abiraterone—Rash—Erlotinib—kidney cancer	0.00018	0.000728	CcSEcCtD
Abiraterone—Dermatitis—Erlotinib—kidney cancer	0.000179	0.000727	CcSEcCtD
Abiraterone—Insomnia—Gemcitabine—kidney cancer	0.000179	0.000725	CcSEcCtD
Abiraterone—Constipation—Vincristine—kidney cancer	0.000178	0.000723	CcSEcCtD
Abiraterone—Cardiac disorder—Capecitabine—kidney cancer	0.000177	0.00072	CcSEcCtD
Abiraterone—Cough—Paclitaxel—kidney cancer	0.000177	0.000718	CcSEcCtD
Abiraterone—Asthenia—Sunitinib—kidney cancer	0.000177	0.000717	CcSEcCtD
Abiraterone—Dyspnoea—Gemcitabine—kidney cancer	0.000176	0.000715	CcSEcCtD
Abiraterone—Diarrhoea—Sorafenib—kidney cancer	0.000175	0.000711	CcSEcCtD
Abiraterone—Hypertension—Paclitaxel—kidney cancer	0.000175	0.00071	CcSEcCtD
Abiraterone—Angiopathy—Capecitabine—kidney cancer	0.000174	0.000704	CcSEcCtD
Abiraterone—Myalgia—Paclitaxel—kidney cancer	0.000173	0.0007	CcSEcCtD
Abiraterone—Chest pain—Paclitaxel—kidney cancer	0.000173	0.0007	CcSEcCtD
Abiraterone—Mediastinal disorder—Capecitabine—kidney cancer	0.000172	0.000699	CcSEcCtD
Abiraterone—Unspecified disorder of skin and subcutaneous tissue—Paclitaxel—kidney cancer	0.000172	0.000696	CcSEcCtD
Abiraterone—Arrhythmia—Capecitabine—kidney cancer	0.000171	0.000693	CcSEcCtD
Abiraterone—Gastrointestinal disorder—Gemcitabine—kidney cancer	0.000171	0.000692	CcSEcCtD
Abiraterone—Discomfort—Paclitaxel—kidney cancer	0.000171	0.000692	CcSEcCtD
Abiraterone—Fatigue—Gemcitabine—kidney cancer	0.00017	0.000691	CcSEcCtD
Abiraterone—Constipation—Gemcitabine—kidney cancer	0.000169	0.000686	CcSEcCtD
Abiraterone—Diarrhoea—Sunitinib—kidney cancer	0.000169	0.000684	CcSEcCtD
Abiraterone—Mental disorder—Capecitabine—kidney cancer	0.000168	0.00068	CcSEcCtD
Abiraterone—Asthenia—Dactinomycin—kidney cancer	0.000167	0.000679	CcSEcCtD
Abiraterone—Oedema—Paclitaxel—kidney cancer	0.000166	0.000671	CcSEcCtD
Abiraterone—Body temperature increased—Vincristine—kidney cancer	0.000165	0.000668	CcSEcCtD
Abiraterone—Infection—Paclitaxel—kidney cancer	0.000164	0.000667	CcSEcCtD
Abiraterone—Vomiting—Sorafenib—kidney cancer	0.000163	0.00066	CcSEcCtD
Abiraterone—Hypokalaemia—Doxorubicin—kidney cancer	0.000162	0.000658	CcSEcCtD
Abiraterone—Rash—Sorafenib—kidney cancer	0.000161	0.000655	CcSEcCtD
Abiraterone—Dermatitis—Sorafenib—kidney cancer	0.000161	0.000654	CcSEcCtD
Abiraterone—Skin disorder—Paclitaxel—kidney cancer	0.000161	0.000652	CcSEcCtD
Abiraterone—Aspartate aminotransferase increased—Doxorubicin—kidney cancer	0.00016	0.000651	CcSEcCtD
Abiraterone—Diarrhoea—Dactinomycin—kidney cancer	0.00016	0.000647	CcSEcCtD
Abiraterone—Nasopharyngitis—Doxorubicin—kidney cancer	0.000159	0.000646	CcSEcCtD
Abiraterone—Alanine aminotransferase increased—Doxorubicin—kidney cancer	0.000157	0.000637	CcSEcCtD
Abiraterone—Vomiting—Sunitinib—kidney cancer	0.000157	0.000636	CcSEcCtD
Abiraterone—Body temperature increased—Gemcitabine—kidney cancer	0.000156	0.000634	CcSEcCtD
Abiraterone—Rash—Sunitinib—kidney cancer	0.000155	0.00063	CcSEcCtD
Abiraterone—Dermatitis—Sunitinib—kidney cancer	0.000155	0.00063	CcSEcCtD
Abiraterone—Anaemia—Capecitabine—kidney cancer	0.000154	0.000624	CcSEcCtD
Abiraterone—Musculoskeletal discomfort—Paclitaxel—kidney cancer	0.000151	0.000612	CcSEcCtD
Abiraterone—Insomnia—Paclitaxel—kidney cancer	0.00015	0.000607	CcSEcCtD
Abiraterone—Asthenia—Vincristine—kidney cancer	0.00015	0.000607	CcSEcCtD
Abiraterone—Vomiting—Dactinomycin—kidney cancer	0.000148	0.000602	CcSEcCtD
Abiraterone—Dyspnoea—Paclitaxel—kidney cancer	0.000148	0.000599	CcSEcCtD
Abiraterone—Rash—Dactinomycin—kidney cancer	0.000147	0.000597	CcSEcCtD
Abiraterone—Dyspepsia—Paclitaxel—kidney cancer	0.000146	0.000591	CcSEcCtD
Abiraterone—Cough—Capecitabine—kidney cancer	0.000145	0.000589	CcSEcCtD
Abiraterone—Hypertension—Capecitabine—kidney cancer	0.000144	0.000583	CcSEcCtD
Abiraterone—Upper respiratory tract infection—Doxorubicin—kidney cancer	0.000143	0.000581	CcSEcCtD
Abiraterone—Gastrointestinal disorder—Paclitaxel—kidney cancer	0.000143	0.00058	CcSEcCtD
Abiraterone—Fatigue—Paclitaxel—kidney cancer	0.000143	0.000579	CcSEcCtD
Abiraterone—Diarrhoea—Vincristine—kidney cancer	0.000143	0.000578	CcSEcCtD
Abiraterone—Pollakiuria—Doxorubicin—kidney cancer	0.000142	0.000577	CcSEcCtD
Abiraterone—Asthenia—Gemcitabine—kidney cancer	0.000142	0.000575	CcSEcCtD
Abiraterone—Myalgia—Capecitabine—kidney cancer	0.000142	0.000575	CcSEcCtD
Abiraterone—Chest pain—Capecitabine—kidney cancer	0.000142	0.000575	CcSEcCtD
Abiraterone—Constipation—Paclitaxel—kidney cancer	0.000142	0.000574	CcSEcCtD
Abiraterone—Unspecified disorder of skin and subcutaneous tissue—Capecitabine—kidney cancer	0.000141	0.000571	CcSEcCtD
Abiraterone—Discomfort—Capecitabine—kidney cancer	0.00014	0.000568	CcSEcCtD
Abiraterone—Hyperglycaemia—Doxorubicin—kidney cancer	0.000139	0.000563	CcSEcCtD
Abiraterone—Pneumonia—Doxorubicin—kidney cancer	0.000138	0.00056	CcSEcCtD
Abiraterone—Infestation—Doxorubicin—kidney cancer	0.000137	0.000557	CcSEcCtD
Abiraterone—Infestation NOS—Doxorubicin—kidney cancer	0.000137	0.000557	CcSEcCtD
Abiraterone—Oedema—Capecitabine—kidney cancer	0.000136	0.000551	CcSEcCtD
Abiraterone—Diarrhoea—Gemcitabine—kidney cancer	0.000135	0.000549	CcSEcCtD
Abiraterone—Infection—Capecitabine—kidney cancer	0.000135	0.000547	CcSEcCtD
Abiraterone—Urinary tract infection—Doxorubicin—kidney cancer	0.000133	0.000541	CcSEcCtD
Abiraterone—Vomiting—Vincristine—kidney cancer	0.000133	0.000538	CcSEcCtD
Abiraterone—Skin disorder—Capecitabine—kidney cancer	0.000132	0.000535	CcSEcCtD
Abiraterone—Rash—Vincristine—kidney cancer	0.000131	0.000533	CcSEcCtD
Abiraterone—Dermatitis—Vincristine—kidney cancer	0.000131	0.000533	CcSEcCtD
Abiraterone—Haematuria—Doxorubicin—kidney cancer	0.000131	0.000531	CcSEcCtD
Abiraterone—Body temperature increased—Paclitaxel—kidney cancer	0.000131	0.000531	CcSEcCtD
Abiraterone—Vomiting—Gemcitabine—kidney cancer	0.000126	0.00051	CcSEcCtD
Abiraterone—Rash—Gemcitabine—kidney cancer	0.000125	0.000506	CcSEcCtD
Abiraterone—Dermatitis—Gemcitabine—kidney cancer	0.000125	0.000505	CcSEcCtD
Abiraterone—Musculoskeletal discomfort—Capecitabine—kidney cancer	0.000124	0.000502	CcSEcCtD
Abiraterone—Insomnia—Capecitabine—kidney cancer	0.000123	0.000498	CcSEcCtD
Abiraterone—Urinary tract disorder—Doxorubicin—kidney cancer	0.000122	0.000494	CcSEcCtD
Abiraterone—Connective tissue disorder—Doxorubicin—kidney cancer	0.000121	0.000491	CcSEcCtD
Abiraterone—Dyspnoea—Capecitabine—kidney cancer	0.000121	0.000491	CcSEcCtD
Abiraterone—Urethral disorder—Doxorubicin—kidney cancer	0.000121	0.00049	CcSEcCtD
Abiraterone—Dyspepsia—Capecitabine—kidney cancer	0.00012	0.000485	CcSEcCtD
Abiraterone—Asthenia—Paclitaxel—kidney cancer	0.000119	0.000482	CcSEcCtD
Abiraterone—Gastrointestinal disorder—Capecitabine—kidney cancer	0.000117	0.000476	CcSEcCtD
Abiraterone—Fatigue—Capecitabine—kidney cancer	0.000117	0.000475	CcSEcCtD
Abiraterone—Constipation—Capecitabine—kidney cancer	0.000116	0.000471	CcSEcCtD
Abiraterone—Cardiac disorder—Doxorubicin—kidney cancer	0.000114	0.000464	CcSEcCtD
Abiraterone—Diarrhoea—Paclitaxel—kidney cancer	0.000113	0.000459	CcSEcCtD
Abiraterone—Angiopathy—Doxorubicin—kidney cancer	0.000112	0.000454	CcSEcCtD
Abiraterone—Mediastinal disorder—Doxorubicin—kidney cancer	0.000111	0.000451	CcSEcCtD
Abiraterone—Arrhythmia—Doxorubicin—kidney cancer	0.00011	0.000447	CcSEcCtD
Abiraterone—Mental disorder—Doxorubicin—kidney cancer	0.000108	0.000438	CcSEcCtD
Abiraterone—Body temperature increased—Capecitabine—kidney cancer	0.000107	0.000436	CcSEcCtD
Abiraterone—Vomiting—Paclitaxel—kidney cancer	0.000105	0.000427	CcSEcCtD
Abiraterone—Rash—Paclitaxel—kidney cancer	0.000104	0.000423	CcSEcCtD
Abiraterone—Dermatitis—Paclitaxel—kidney cancer	0.000104	0.000423	CcSEcCtD
Abiraterone—Anaemia—Doxorubicin—kidney cancer	9.92e-05	0.000402	CcSEcCtD
Abiraterone—Asthenia—Capecitabine—kidney cancer	9.75e-05	0.000395	CcSEcCtD
Abiraterone—Cough—Doxorubicin—kidney cancer	9.36e-05	0.00038	CcSEcCtD
Abiraterone—Diarrhoea—Capecitabine—kidney cancer	9.3e-05	0.000377	CcSEcCtD
Abiraterone—Hypertension—Doxorubicin—kidney cancer	9.27e-05	0.000376	CcSEcCtD
Abiraterone—Myalgia—Doxorubicin—kidney cancer	9.14e-05	0.000371	CcSEcCtD
Abiraterone—Chest pain—Doxorubicin—kidney cancer	9.14e-05	0.000371	CcSEcCtD
Abiraterone—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—kidney cancer	9.07e-05	0.000368	CcSEcCtD
Abiraterone—Discomfort—Doxorubicin—kidney cancer	9.03e-05	0.000366	CcSEcCtD
Abiraterone—Oedema—Doxorubicin—kidney cancer	8.76e-05	0.000355	CcSEcCtD
Abiraterone—Infection—Doxorubicin—kidney cancer	8.7e-05	0.000353	CcSEcCtD
Abiraterone—Vomiting—Capecitabine—kidney cancer	8.64e-05	0.00035	CcSEcCtD
Abiraterone—Rash—Capecitabine—kidney cancer	8.57e-05	0.000347	CcSEcCtD
Abiraterone—Dermatitis—Capecitabine—kidney cancer	8.56e-05	0.000347	CcSEcCtD
Abiraterone—Skin disorder—Doxorubicin—kidney cancer	8.51e-05	0.000345	CcSEcCtD
Abiraterone—Musculoskeletal discomfort—Doxorubicin—kidney cancer	7.98e-05	0.000324	CcSEcCtD
Abiraterone—Insomnia—Doxorubicin—kidney cancer	7.92e-05	0.000321	CcSEcCtD
Abiraterone—Dyspnoea—Doxorubicin—kidney cancer	7.81e-05	0.000317	CcSEcCtD
Abiraterone—Dyspepsia—Doxorubicin—kidney cancer	7.71e-05	0.000313	CcSEcCtD
Abiraterone—Gastrointestinal disorder—Doxorubicin—kidney cancer	7.56e-05	0.000307	CcSEcCtD
Abiraterone—Fatigue—Doxorubicin—kidney cancer	7.55e-05	0.000306	CcSEcCtD
Abiraterone—Constipation—Doxorubicin—kidney cancer	7.49e-05	0.000304	CcSEcCtD
Abiraterone—Body temperature increased—Doxorubicin—kidney cancer	6.92e-05	0.000281	CcSEcCtD
Abiraterone—Asthenia—Doxorubicin—kidney cancer	6.28e-05	0.000255	CcSEcCtD
Abiraterone—Diarrhoea—Doxorubicin—kidney cancer	5.99e-05	0.000243	CcSEcCtD
Abiraterone—Vomiting—Doxorubicin—kidney cancer	5.57e-05	0.000226	CcSEcCtD
Abiraterone—Rash—Doxorubicin—kidney cancer	5.52e-05	0.000224	CcSEcCtD
Abiraterone—Dermatitis—Doxorubicin—kidney cancer	5.52e-05	0.000224	CcSEcCtD
Abiraterone—CYP17A1—Metabolism—BCHE—kidney cancer	3.51e-05	0.000506	CbGpPWpGaD
Abiraterone—CYP2C8—Metabolism—PDHB—kidney cancer	3.5e-05	0.000506	CbGpPWpGaD
Abiraterone—ALB—Metabolism of lipids and lipoproteins—CRABP1—kidney cancer	3.49e-05	0.000504	CbGpPWpGaD
Abiraterone—CYP2C8—Biological oxidations—POMC—kidney cancer	3.49e-05	0.000504	CbGpPWpGaD
Abiraterone—ALB—Metabolism—PDHB—kidney cancer	3.48e-05	0.000503	CbGpPWpGaD
Abiraterone—CYP17A1—Metabolism—SLC5A5—kidney cancer	3.46e-05	0.0005	CbGpPWpGaD
Abiraterone—SULT2A1—Metabolism—POMC—kidney cancer	3.42e-05	0.000493	CbGpPWpGaD
Abiraterone—ABCC1—Transmembrane transport of small molecules—ABCB1—kidney cancer	3.4e-05	0.000491	CbGpPWpGaD
Abiraterone—CYP2D6—Metabolism—ACY1—kidney cancer	3.38e-05	0.000488	CbGpPWpGaD
Abiraterone—ABCC1—Metabolism—CA9—kidney cancer	3.37e-05	0.000486	CbGpPWpGaD
Abiraterone—CYP17A1—Metabolism—SLC2A1—kidney cancer	3.35e-05	0.000483	CbGpPWpGaD
Abiraterone—ABCC1—Metabolism of lipids and lipoproteins—CYP1A1—kidney cancer	3.29e-05	0.000475	CbGpPWpGaD
Abiraterone—CYP2C8—Metabolism—CCBL1—kidney cancer	3.29e-05	0.000475	CbGpPWpGaD
Abiraterone—ALB—Metabolism—CCBL1—kidney cancer	3.27e-05	0.000473	CbGpPWpGaD
Abiraterone—CYP17A1—Metabolism of lipids and lipoproteins—PTGS2—kidney cancer	3.25e-05	0.000469	CbGpPWpGaD
Abiraterone—ABCC1—Disease—ITPR2—kidney cancer	3.18e-05	0.000459	CbGpPWpGaD
Abiraterone—CYP2C8—Metabolism of lipids and lipoproteins—ACHE—kidney cancer	2.98e-05	0.00043	CbGpPWpGaD
Abiraterone—ALB—Metabolism of lipids and lipoproteins—ACHE—kidney cancer	2.96e-05	0.000427	CbGpPWpGaD
Abiraterone—CYP3A4—Biological oxidations—GSTP1—kidney cancer	2.88e-05	0.000416	CbGpPWpGaD
Abiraterone—CYP2D6—Metabolism—PDHB—kidney cancer	2.87e-05	0.000415	CbGpPWpGaD
Abiraterone—CYP2D6—Biological oxidations—POMC—kidney cancer	2.87e-05	0.000414	CbGpPWpGaD
Abiraterone—ABCC1—Metabolism—CRABP1—kidney cancer	2.86e-05	0.000413	CbGpPWpGaD
Abiraterone—CYP2C8—Metabolism—GLIPR1—kidney cancer	2.85e-05	0.000412	CbGpPWpGaD
Abiraterone—CYP2C8—Metabolism—PPAT—kidney cancer	2.85e-05	0.000412	CbGpPWpGaD
Abiraterone—CYP3A4—Metapathway biotransformation—GSTP1—kidney cancer	2.85e-05	0.000411	CbGpPWpGaD
Abiraterone—ALB—Metabolism—GLIPR1—kidney cancer	2.84e-05	0.00041	CbGpPWpGaD
Abiraterone—ALB—Metabolism—PPAT—kidney cancer	2.84e-05	0.00041	CbGpPWpGaD
Abiraterone—CYP17A1—Metabolism of lipids and lipoproteins—PTEN—kidney cancer	2.83e-05	0.000409	CbGpPWpGaD
Abiraterone—CYP2C8—Metabolism of lipids and lipoproteins—SCARB1—kidney cancer	2.82e-05	0.000407	CbGpPWpGaD
Abiraterone—ALB—Metabolism of lipids and lipoproteins—SCARB1—kidney cancer	2.8e-05	0.000405	CbGpPWpGaD
Abiraterone—CYP17A1—Metabolism—GSTP1—kidney cancer	2.79e-05	0.000403	CbGpPWpGaD
Abiraterone—CYP2C8—Metabolism of lipids and lipoproteins—PTGS1—kidney cancer	2.79e-05	0.000403	CbGpPWpGaD
Abiraterone—ALB—Metabolism of lipids and lipoproteins—PTGS1—kidney cancer	2.77e-05	0.0004	CbGpPWpGaD
Abiraterone—SULT2A1—Metabolism—PTGS2—kidney cancer	2.72e-05	0.000393	CbGpPWpGaD
Abiraterone—CYP2D6—Metabolism—CCBL1—kidney cancer	2.7e-05	0.00039	CbGpPWpGaD
Abiraterone—ABCC1—Disease—PSMD7—kidney cancer	2.66e-05	0.000385	CbGpPWpGaD
Abiraterone—ABCC1—Metabolism—ITPR2—kidney cancer	2.66e-05	0.000384	CbGpPWpGaD
Abiraterone—CYP2C8—Metabolism—APRT—kidney cancer	2.65e-05	0.000383	CbGpPWpGaD
Abiraterone—CYP2C8—Metabolism—FH—kidney cancer	2.65e-05	0.000383	CbGpPWpGaD
Abiraterone—CYP3A4—Biological oxidations—GSTM1—kidney cancer	2.65e-05	0.000383	CbGpPWpGaD
Abiraterone—CYP17A1—Metabolism—ABCB1—kidney cancer	2.64e-05	0.000381	CbGpPWpGaD
Abiraterone—ALB—Metabolism—APRT—kidney cancer	2.64e-05	0.000381	CbGpPWpGaD
Abiraterone—ALB—Metabolism—FH—kidney cancer	2.64e-05	0.000381	CbGpPWpGaD
Abiraterone—ALB—Hemostasis—IFNA1—kidney cancer	2.62e-05	0.000378	CbGpPWpGaD
Abiraterone—CYP3A4—Metapathway biotransformation—GSTM1—kidney cancer	2.61e-05	0.000377	CbGpPWpGaD
Abiraterone—CYP2C8—Metabolism of lipids and lipoproteins—BCHE—kidney cancer	2.59e-05	0.000374	CbGpPWpGaD
Abiraterone—ALB—Metabolism of lipids and lipoproteins—BCHE—kidney cancer	2.58e-05	0.000372	CbGpPWpGaD
Abiraterone—CYP17A1—Metabolism—GSTM1—kidney cancer	2.56e-05	0.00037	CbGpPWpGaD
Abiraterone—CYP3A4—Biological oxidations—CYP1A1—kidney cancer	2.51e-05	0.000363	CbGpPWpGaD
Abiraterone—CYP2C8—Metabolism—GPC3—kidney cancer	2.5e-05	0.00036	CbGpPWpGaD
Abiraterone—ALB—Metabolism—GPC3—kidney cancer	2.48e-05	0.000358	CbGpPWpGaD
Abiraterone—CYP3A4—Metapathway biotransformation—CYP1A1—kidney cancer	2.48e-05	0.000358	CbGpPWpGaD
Abiraterone—ABCC1—Metabolism of lipids and lipoproteins—POMC—kidney cancer	2.45e-05	0.000354	CbGpPWpGaD
Abiraterone—ALB—Hemostasis—IFNA2—kidney cancer	2.44e-05	0.000352	CbGpPWpGaD
Abiraterone—CYP17A1—Metabolism—CYP1A1—kidney cancer	2.43e-05	0.000351	CbGpPWpGaD
Abiraterone—ABCC1—Metabolism—ACHE—kidney cancer	2.43e-05	0.000351	CbGpPWpGaD
Abiraterone—ABCC1—Metabolism—GSTT1—kidney cancer	2.43e-05	0.000351	CbGpPWpGaD
Abiraterone—CYP2C8—Metabolism—CA2—kidney cancer	2.43e-05	0.00035	CbGpPWpGaD
Abiraterone—ALB—Transmembrane transport of small molecules—SLC5A5—kidney cancer	2.42e-05	0.00035	CbGpPWpGaD
Abiraterone—ALB—Metabolism—CA2—kidney cancer	2.41e-05	0.000348	CbGpPWpGaD
Abiraterone—ABCC1—Disease—SLC2A1—kidney cancer	2.41e-05	0.000348	CbGpPWpGaD
Abiraterone—ABCC1—Disease—JUNB—kidney cancer	2.39e-05	0.000345	CbGpPWpGaD
Abiraterone—SULT2A1—Metabolism—PTEN—kidney cancer	2.38e-05	0.000343	CbGpPWpGaD
Abiraterone—CYP2C8—Metabolism—ALAD—kidney cancer	2.37e-05	0.000341	CbGpPWpGaD
Abiraterone—ALB—Metabolism—ALAD—kidney cancer	2.35e-05	0.00034	CbGpPWpGaD
Abiraterone—CYP2D6—Metabolism—PPAT—kidney cancer	2.34e-05	0.000338	CbGpPWpGaD
Abiraterone—CYP2D6—Metabolism—GLIPR1—kidney cancer	2.34e-05	0.000338	CbGpPWpGaD
Abiraterone—ALB—Platelet activation, signaling and aggregation—RAF1—kidney cancer	2.34e-05	0.000338	CbGpPWpGaD
Abiraterone—ALB—Transmembrane transport of small molecules—SLC2A1—kidney cancer	2.34e-05	0.000338	CbGpPWpGaD
Abiraterone—CYP2C8—Metabolism—ST3GAL2—kidney cancer	2.31e-05	0.000333	CbGpPWpGaD
Abiraterone—ABCC1—Metabolism—SCARB1—kidney cancer	2.3e-05	0.000332	CbGpPWpGaD
Abiraterone—ALB—Metabolism—ST3GAL2—kidney cancer	2.3e-05	0.000331	CbGpPWpGaD
Abiraterone—ABCC1—Metabolism—PTGS1—kidney cancer	2.28e-05	0.000328	CbGpPWpGaD
Abiraterone—CYP2C8—Metabolism—ALDH1A1—kidney cancer	2.26e-05	0.000326	CbGpPWpGaD
Abiraterone—ALB—Metabolism—ALDH1A1—kidney cancer	2.24e-05	0.000324	CbGpPWpGaD
Abiraterone—ABCC1—Metabolism—PSMD7—kidney cancer	2.23e-05	0.000322	CbGpPWpGaD
Abiraterone—CYP3A4—Metabolism—ACY1—kidney cancer	2.21e-05	0.000319	CbGpPWpGaD
Abiraterone—ALB—Hemostasis—IGF2—kidney cancer	2.19e-05	0.000317	CbGpPWpGaD
Abiraterone—CYP2D6—Metabolism—FH—kidney cancer	2.18e-05	0.000315	CbGpPWpGaD
Abiraterone—CYP2D6—Metabolism—APRT—kidney cancer	2.18e-05	0.000315	CbGpPWpGaD
Abiraterone—CYP2C8—Metabolism—PGK1—kidney cancer	2.16e-05	0.000312	CbGpPWpGaD
Abiraterone—CYP2C8—Metabolism—SLC5A3—kidney cancer	2.16e-05	0.000312	CbGpPWpGaD
Abiraterone—ALB—Metabolism—PGK1—kidney cancer	2.15e-05	0.000311	CbGpPWpGaD
Abiraterone—ALB—Metabolism—SLC5A3—kidney cancer	2.15e-05	0.000311	CbGpPWpGaD
Abiraterone—CYP2C8—Metabolism—LDHB—kidney cancer	2.12e-05	0.000306	CbGpPWpGaD
Abiraterone—ABCC1—Metabolism—BCHE—kidney cancer	2.12e-05	0.000305	CbGpPWpGaD
Abiraterone—ALB—Metabolism—LDHB—kidney cancer	2.11e-05	0.000305	CbGpPWpGaD
Abiraterone—ALB—Platelet activation, signaling and aggregation—IL2—kidney cancer	2.1e-05	0.000303	CbGpPWpGaD
Abiraterone—ABCC1—Metabolism—SLC5A5—kidney cancer	2.09e-05	0.000302	CbGpPWpGaD
Abiraterone—CYP2D6—Metabolism—GPC3—kidney cancer	2.05e-05	0.000296	CbGpPWpGaD
Abiraterone—ABCC1—Metabolism—SLC2A1—kidney cancer	2.02e-05	0.000291	CbGpPWpGaD
Abiraterone—CYP17A1—Metabolism of lipids and lipoproteins—PIK3CA—kidney cancer	2e-05	0.000288	CbGpPWpGaD
Abiraterone—CYP2D6—Metabolism—CA2—kidney cancer	1.99e-05	0.000288	CbGpPWpGaD
Abiraterone—ABCC1—Metabolism of lipids and lipoproteins—PTGS2—kidney cancer	1.96e-05	0.000283	CbGpPWpGaD
Abiraterone—ABCC1—Disease—CDKN2B—kidney cancer	1.95e-05	0.000281	CbGpPWpGaD
Abiraterone—CYP2D6—Metabolism—ALAD—kidney cancer	1.94e-05	0.00028	CbGpPWpGaD
Abiraterone—ABCC1—Transmembrane transport of small molecules—RAF1—kidney cancer	1.92e-05	0.000278	CbGpPWpGaD
Abiraterone—CYP2D6—Metabolism—ST3GAL2—kidney cancer	1.9e-05	0.000274	CbGpPWpGaD
Abiraterone—CYP3A4—Metabolism—PDHB—kidney cancer	1.88e-05	0.000271	CbGpPWpGaD
Abiraterone—CYP3A4—Biological oxidations—POMC—kidney cancer	1.87e-05	0.00027	CbGpPWpGaD
Abiraterone—CYP2D6—Metabolism—ALDH1A1—kidney cancer	1.85e-05	0.000267	CbGpPWpGaD
Abiraterone—ALB—Transmembrane transport of small molecules—ABCB1—kidney cancer	1.85e-05	0.000267	CbGpPWpGaD
Abiraterone—CYP2C8—Metabolism—CA9—kidney cancer	1.84e-05	0.000266	CbGpPWpGaD
Abiraterone—ALB—Metabolism—CA9—kidney cancer	1.83e-05	0.000264	CbGpPWpGaD
Abiraterone—CYP17A1—Metabolism—POMC—kidney cancer	1.81e-05	0.000262	CbGpPWpGaD
Abiraterone—CYP2C8—Metabolism of lipids and lipoproteins—CYP1A1—kidney cancer	1.8e-05	0.00026	CbGpPWpGaD
Abiraterone—ALB—Metabolism of lipids and lipoproteins—CYP1A1—kidney cancer	1.79e-05	0.000258	CbGpPWpGaD
Abiraterone—ALB—Platelet activation, signaling and aggregation—VEGFA—kidney cancer	1.78e-05	0.000258	CbGpPWpGaD
Abiraterone—CYP2D6—Metabolism—PGK1—kidney cancer	1.78e-05	0.000256	CbGpPWpGaD
Abiraterone—CYP2D6—Metabolism—SLC5A3—kidney cancer	1.78e-05	0.000256	CbGpPWpGaD
Abiraterone—CYP3A4—Metabolism—CCBL1—kidney cancer	1.77e-05	0.000255	CbGpPWpGaD
Abiraterone—CYP2D6—Metabolism—LDHB—kidney cancer	1.74e-05	0.000251	CbGpPWpGaD
Abiraterone—ABCC1—Metabolism of lipids and lipoproteins—PTEN—kidney cancer	1.71e-05	0.000247	CbGpPWpGaD
Abiraterone—ALB—Platelet activation, signaling and aggregation—MAPK3—kidney cancer	1.69e-05	0.000244	CbGpPWpGaD
Abiraterone—ABCC1—Metabolism—GSTP1—kidney cancer	1.68e-05	0.000243	CbGpPWpGaD
Abiraterone—SULT2A1—Metabolism—PIK3CA—kidney cancer	1.68e-05	0.000242	CbGpPWpGaD
Abiraterone—ALB—Platelet activation, signaling and aggregation—MAPK1—kidney cancer	1.61e-05	0.000232	CbGpPWpGaD
Abiraterone—ABCC1—Metabolism—ABCB1—kidney cancer	1.59e-05	0.00023	CbGpPWpGaD
Abiraterone—CYP2C8—Metabolism—CRABP1—kidney cancer	1.56e-05	0.000226	CbGpPWpGaD
Abiraterone—ABCC1—Disease—HIF1A—kidney cancer	1.56e-05	0.000225	CbGpPWpGaD
Abiraterone—ALB—Metabolism—CRABP1—kidney cancer	1.56e-05	0.000225	CbGpPWpGaD
Abiraterone—ABCC1—Disease—TSC2—kidney cancer	1.55e-05	0.000224	CbGpPWpGaD
Abiraterone—ABCC1—Metabolism—GSTM1—kidney cancer	1.55e-05	0.000223	CbGpPWpGaD
Abiraterone—CYP3A4—Metabolism—GLIPR1—kidney cancer	1.53e-05	0.000221	CbGpPWpGaD
Abiraterone—CYP3A4—Metabolism—PPAT—kidney cancer	1.53e-05	0.000221	CbGpPWpGaD
Abiraterone—CYP2D6—Metabolism—CA9—kidney cancer	1.51e-05	0.000218	CbGpPWpGaD
Abiraterone—ABCC1—Metabolism—CYP1A1—kidney cancer	1.47e-05	0.000212	CbGpPWpGaD
Abiraterone—CYP2C8—Metabolism—ITPR2—kidney cancer	1.45e-05	0.00021	CbGpPWpGaD
Abiraterone—ALB—Metabolism—ITPR2—kidney cancer	1.45e-05	0.000209	CbGpPWpGaD
Abiraterone—CYP17A1—Metabolism—PTGS2—kidney cancer	1.45e-05	0.000209	CbGpPWpGaD
Abiraterone—CYP3A4—Metabolism—FH—kidney cancer	1.42e-05	0.000206	CbGpPWpGaD
Abiraterone—CYP3A4—Metabolism—APRT—kidney cancer	1.42e-05	0.000206	CbGpPWpGaD
Abiraterone—ALB—Platelet activation, signaling and aggregation—PIK3CA—kidney cancer	1.39e-05	0.000201	CbGpPWpGaD
Abiraterone—ABCC1—Disease—KIT—kidney cancer	1.37e-05	0.000198	CbGpPWpGaD
Abiraterone—ABCC1—Disease—APC—kidney cancer	1.37e-05	0.000198	CbGpPWpGaD
Abiraterone—CYP2C8—Metabolism of lipids and lipoproteins—POMC—kidney cancer	1.34e-05	0.000194	CbGpPWpGaD
Abiraterone—CYP3A4—Metabolism—GPC3—kidney cancer	1.34e-05	0.000193	CbGpPWpGaD
Abiraterone—ALB—Metabolism of lipids and lipoproteins—POMC—kidney cancer	1.33e-05	0.000192	CbGpPWpGaD
Abiraterone—CYP2C8—Metabolism—GSTT1—kidney cancer	1.33e-05	0.000191	CbGpPWpGaD
Abiraterone—CYP2C8—Metabolism—ACHE—kidney cancer	1.33e-05	0.000191	CbGpPWpGaD
Abiraterone—ALB—Metabolism—GSTT1—kidney cancer	1.32e-05	0.00019	CbGpPWpGaD
Abiraterone—ALB—Metabolism—ACHE—kidney cancer	1.32e-05	0.00019	CbGpPWpGaD
Abiraterone—CYP3A4—Metabolism—CA2—kidney cancer	1.3e-05	0.000188	CbGpPWpGaD
Abiraterone—ABCC1—Disease—BRAF—kidney cancer	1.29e-05	0.000186	CbGpPWpGaD
Abiraterone—CYP2D6—Metabolism—CRABP1—kidney cancer	1.28e-05	0.000185	CbGpPWpGaD
Abiraterone—CYP3A4—Metabolism—ALAD—kidney cancer	1.27e-05	0.000183	CbGpPWpGaD
Abiraterone—CYP17A1—Metabolism—PTEN—kidney cancer	1.26e-05	0.000182	CbGpPWpGaD
Abiraterone—CYP2C8—Metabolism—SCARB1—kidney cancer	1.26e-05	0.000181	CbGpPWpGaD
Abiraterone—ALB—Metabolism—SCARB1—kidney cancer	1.25e-05	0.00018	CbGpPWpGaD
Abiraterone—CYP2C8—Metabolism—PTGS1—kidney cancer	1.24e-05	0.000179	CbGpPWpGaD
Abiraterone—CYP3A4—Metabolism—ST3GAL2—kidney cancer	1.24e-05	0.000179	CbGpPWpGaD
Abiraterone—ALB—Metabolism—PTGS1—kidney cancer	1.24e-05	0.000178	CbGpPWpGaD
Abiraterone—CYP2C8—Metabolism—PSMD7—kidney cancer	1.22e-05	0.000176	CbGpPWpGaD
Abiraterone—ALB—Metabolism—PSMD7—kidney cancer	1.21e-05	0.000175	CbGpPWpGaD
Abiraterone—CYP3A4—Metabolism—ALDH1A1—kidney cancer	1.21e-05	0.000175	CbGpPWpGaD
Abiraterone—ALB—Hemostasis—RAF1—kidney cancer	1.21e-05	0.000174	CbGpPWpGaD
Abiraterone—ABCC1—Metabolism of lipids and lipoproteins—PIK3CA—kidney cancer	1.2e-05	0.000174	CbGpPWpGaD
Abiraterone—CYP2D6—Metabolism—ITPR2—kidney cancer	1.19e-05	0.000172	CbGpPWpGaD
Abiraterone—CYP3A4—Metabolism—PGK1—kidney cancer	1.16e-05	0.000168	CbGpPWpGaD
Abiraterone—CYP3A4—Metabolism—SLC5A3—kidney cancer	1.16e-05	0.000168	CbGpPWpGaD
Abiraterone—CYP2C8—Metabolism—BCHE—kidney cancer	1.16e-05	0.000167	CbGpPWpGaD
Abiraterone—ALB—Metabolism—BCHE—kidney cancer	1.15e-05	0.000166	CbGpPWpGaD
Abiraterone—CYP2C8—Metabolism—SLC5A5—kidney cancer	1.14e-05	0.000165	CbGpPWpGaD
Abiraterone—CYP3A4—Metabolism—LDHB—kidney cancer	1.14e-05	0.000164	CbGpPWpGaD
Abiraterone—ALB—Metabolism—SLC5A5—kidney cancer	1.13e-05	0.000164	CbGpPWpGaD
Abiraterone—CYP2C8—Metabolism—SLC2A1—kidney cancer	1.1e-05	0.000159	CbGpPWpGaD
Abiraterone—ALB—Metabolism—SLC2A1—kidney cancer	1.1e-05	0.000158	CbGpPWpGaD
Abiraterone—ABCC1—Metabolism—POMC—kidney cancer	1.09e-05	0.000158	CbGpPWpGaD
Abiraterone—CYP2D6—Metabolism—GSTT1—kidney cancer	1.09e-05	0.000157	CbGpPWpGaD
Abiraterone—CYP2D6—Metabolism—ACHE—kidney cancer	1.09e-05	0.000157	CbGpPWpGaD
Abiraterone—ALB—Hemostasis—IL2—kidney cancer	1.08e-05	0.000156	CbGpPWpGaD
Abiraterone—ABCC1—Disease—RAF1—kidney cancer	1.08e-05	0.000155	CbGpPWpGaD
Abiraterone—CYP2C8—Metabolism of lipids and lipoproteins—PTGS2—kidney cancer	1.07e-05	0.000154	CbGpPWpGaD
Abiraterone—ABCC1—Disease—ERBB2—kidney cancer	1.06e-05	0.000154	CbGpPWpGaD
Abiraterone—ALB—Metabolism of lipids and lipoproteins—PTGS2—kidney cancer	1.06e-05	0.000153	CbGpPWpGaD
Abiraterone—ABCC1—Disease—MTOR—kidney cancer	1.05e-05	0.000152	CbGpPWpGaD
Abiraterone—ABCC1—Disease—CD4—kidney cancer	1.05e-05	0.000151	CbGpPWpGaD
Abiraterone—ALB—Transmembrane transport of small molecules—RAF1—kidney cancer	1.04e-05	0.000151	CbGpPWpGaD
Abiraterone—ABCC1—Disease—PTGS2—kidney cancer	1.04e-05	0.00015	CbGpPWpGaD
Abiraterone—CYP2D6—Metabolism—SCARB1—kidney cancer	1.03e-05	0.000149	CbGpPWpGaD
Abiraterone—CYP2D6—Metabolism—PTGS1—kidney cancer	1.02e-05	0.000147	CbGpPWpGaD
Abiraterone—CYP2D6—Metabolism—PSMD7—kidney cancer	1e-05	0.000144	CbGpPWpGaD
Abiraterone—CYP3A4—Metabolism—CA9—kidney cancer	9.87e-06	0.000143	CbGpPWpGaD
Abiraterone—ABCC1—Disease—CDKN1B—kidney cancer	9.86e-06	0.000142	CbGpPWpGaD
Abiraterone—CYP2D6—Metabolism—BCHE—kidney cancer	9.48e-06	0.000137	CbGpPWpGaD
Abiraterone—CYP2D6—Metabolism—SLC5A5—kidney cancer	9.37e-06	0.000135	CbGpPWpGaD
Abiraterone—CYP2C8—Metabolism of lipids and lipoproteins—PTEN—kidney cancer	9.32e-06	0.000135	CbGpPWpGaD
Abiraterone—ABCC1—Disease—CTNNB1—kidney cancer	9.32e-06	0.000134	CbGpPWpGaD
Abiraterone—ALB—Metabolism of lipids and lipoproteins—PTEN—kidney cancer	9.27e-06	0.000134	CbGpPWpGaD
Abiraterone—ALB—Hemostasis—VEGFA—kidney cancer	9.2e-06	0.000133	CbGpPWpGaD
Abiraterone—CYP2C8—Metabolism—GSTP1—kidney cancer	9.19e-06	0.000133	CbGpPWpGaD
Abiraterone—ALB—Metabolism—GSTP1—kidney cancer	9.14e-06	0.000132	CbGpPWpGaD
Abiraterone—ABCC1—Disease—PTEN—kidney cancer	9.08e-06	0.000131	CbGpPWpGaD
Abiraterone—CYP2D6—Metabolism—SLC2A1—kidney cancer	9.05e-06	0.000131	CbGpPWpGaD
Abiraterone—CYP17A1—Metabolism—PIK3CA—kidney cancer	8.89e-06	0.000128	CbGpPWpGaD
Abiraterone—ABCC1—Metabolism—PTGS2—kidney cancer	8.72e-06	0.000126	CbGpPWpGaD
Abiraterone—ALB—Hemostasis—MAPK3—kidney cancer	8.7e-06	0.000126	CbGpPWpGaD
Abiraterone—CYP2C8—Metabolism—ABCB1—kidney cancer	8.7e-06	0.000126	CbGpPWpGaD
Abiraterone—ALB—Metabolism—ABCB1—kidney cancer	8.65e-06	0.000125	CbGpPWpGaD
Abiraterone—CYP2C8—Metabolism—GSTM1—kidney cancer	8.45e-06	0.000122	CbGpPWpGaD
Abiraterone—ALB—Metabolism—GSTM1—kidney cancer	8.4e-06	0.000121	CbGpPWpGaD
Abiraterone—CYP3A4—Metabolism—CRABP1—kidney cancer	8.4e-06	0.000121	CbGpPWpGaD
Abiraterone—ALB—Hemostasis—MAPK1—kidney cancer	8.28e-06	0.00012	CbGpPWpGaD
Abiraterone—CYP2C8—Metabolism—CYP1A1—kidney cancer	8.01e-06	0.000116	CbGpPWpGaD
Abiraterone—ALB—Metabolism—CYP1A1—kidney cancer	7.96e-06	0.000115	CbGpPWpGaD
Abiraterone—ALB—Hemostasis—KRAS—kidney cancer	7.82e-06	0.000113	CbGpPWpGaD
Abiraterone—CYP3A4—Metabolism—ITPR2—kidney cancer	7.81e-06	0.000113	CbGpPWpGaD
Abiraterone—ABCC1—Disease—MAPK3—kidney cancer	7.76e-06	0.000112	CbGpPWpGaD
Abiraterone—ABCC1—Metabolism—PTEN—kidney cancer	7.6e-06	0.00011	CbGpPWpGaD
Abiraterone—ABCC1—Disease—MYC—kidney cancer	7.55e-06	0.000109	CbGpPWpGaD
Abiraterone—CYP2D6—Metabolism—GSTP1—kidney cancer	7.55e-06	0.000109	CbGpPWpGaD
Abiraterone—ABCC1—Disease—MAPK1—kidney cancer	7.38e-06	0.000107	CbGpPWpGaD
Abiraterone—ALB—Hemostasis—PIK3CA—kidney cancer	7.18e-06	0.000104	CbGpPWpGaD
Abiraterone—CYP2D6—Metabolism—ABCB1—kidney cancer	7.14e-06	0.000103	CbGpPWpGaD
Abiraterone—CYP3A4—Metabolism—ACHE—kidney cancer	7.12e-06	0.000103	CbGpPWpGaD
Abiraterone—CYP3A4—Metabolism—GSTT1—kidney cancer	7.12e-06	0.000103	CbGpPWpGaD
Abiraterone—ABCC1—Disease—KRAS—kidney cancer	6.97e-06	0.000101	CbGpPWpGaD
Abiraterone—ALB—Hemostasis—TP53—kidney cancer	6.95e-06	0.0001	CbGpPWpGaD
Abiraterone—CYP2D6—Metabolism—GSTM1—kidney cancer	6.93e-06	0.0001	CbGpPWpGaD
Abiraterone—CYP3A4—Metabolism—SCARB1—kidney cancer	6.74e-06	9.73e-05	CbGpPWpGaD
Abiraterone—CYP3A4—Metabolism—PTGS1—kidney cancer	6.67e-06	9.63e-05	CbGpPWpGaD
Abiraterone—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CA—kidney cancer	6.58e-06	9.5e-05	CbGpPWpGaD
Abiraterone—CYP2D6—Metabolism—CYP1A1—kidney cancer	6.57e-06	9.49e-05	CbGpPWpGaD
Abiraterone—ALB—Metabolism of lipids and lipoproteins—PIK3CA—kidney cancer	6.54e-06	9.44e-05	CbGpPWpGaD
Abiraterone—CYP3A4—Metabolism—PSMD7—kidney cancer	6.54e-06	9.44e-05	CbGpPWpGaD
Abiraterone—ABCC1—Disease—PIK3CA—kidney cancer	6.41e-06	9.25e-05	CbGpPWpGaD
Abiraterone—CYP3A4—Metabolism—BCHE—kidney cancer	6.2e-06	8.95e-05	CbGpPWpGaD
Abiraterone—CYP3A4—Metabolism—SLC5A5—kidney cancer	6.12e-06	8.84e-05	CbGpPWpGaD
Abiraterone—CYP2C8—Metabolism—POMC—kidney cancer	5.97e-06	8.62e-05	CbGpPWpGaD
Abiraterone—ALB—Metabolism—POMC—kidney cancer	5.94e-06	8.57e-05	CbGpPWpGaD
Abiraterone—CYP3A4—Metabolism—SLC2A1—kidney cancer	5.92e-06	8.54e-05	CbGpPWpGaD
Abiraterone—ABCC1—Metabolism—PIK3CA—kidney cancer	5.36e-06	7.74e-05	CbGpPWpGaD
Abiraterone—CYP3A4—Metabolism—GSTP1—kidney cancer	4.93e-06	7.12e-05	CbGpPWpGaD
Abiraterone—CYP2D6—Metabolism—POMC—kidney cancer	4.9e-06	7.08e-05	CbGpPWpGaD
Abiraterone—CYP2C8—Metabolism—PTGS2—kidney cancer	4.76e-06	6.87e-05	CbGpPWpGaD
Abiraterone—ALB—Metabolism—PTGS2—kidney cancer	4.73e-06	6.83e-05	CbGpPWpGaD
Abiraterone—CYP3A4—Metabolism—ABCB1—kidney cancer	4.67e-06	6.74e-05	CbGpPWpGaD
Abiraterone—CYP3A4—Metabolism—GSTM1—kidney cancer	4.53e-06	6.54e-05	CbGpPWpGaD
Abiraterone—CYP3A4—Metabolism—CYP1A1—kidney cancer	4.3e-06	6.2e-05	CbGpPWpGaD
Abiraterone—CYP2C8—Metabolism—PTEN—kidney cancer	4.15e-06	5.99e-05	CbGpPWpGaD
Abiraterone—ALB—Metabolism—PTEN—kidney cancer	4.13e-06	5.96e-05	CbGpPWpGaD
Abiraterone—CYP2D6—Metabolism—PTGS2—kidney cancer	3.91e-06	5.64e-05	CbGpPWpGaD
Abiraterone—CYP2D6—Metabolism—PTEN—kidney cancer	3.41e-06	4.92e-05	CbGpPWpGaD
Abiraterone—CYP3A4—Metabolism—POMC—kidney cancer	3.2e-06	4.63e-05	CbGpPWpGaD
Abiraterone—CYP2C8—Metabolism—PIK3CA—kidney cancer	2.93e-06	4.23e-05	CbGpPWpGaD
Abiraterone—ALB—Metabolism—PIK3CA—kidney cancer	2.91e-06	4.21e-05	CbGpPWpGaD
Abiraterone—CYP3A4—Metabolism—PTGS2—kidney cancer	2.56e-06	3.69e-05	CbGpPWpGaD
Abiraterone—CYP2D6—Metabolism—PIK3CA—kidney cancer	2.41e-06	3.47e-05	CbGpPWpGaD
Abiraterone—CYP3A4—Metabolism—PTEN—kidney cancer	2.23e-06	3.22e-05	CbGpPWpGaD
Abiraterone—CYP3A4—Metabolism—PIK3CA—kidney cancer	1.57e-06	2.27e-05	CbGpPWpGaD
